7 results found
The US-India biotech collaboration under TRUST is more than a bilateral game; it can help reshape global value chains and promote inclusive, ethical i
One year on, as India’s BioE3 policy lays the groundwork for a US$300 billion bioeconomy, its success hinges on closing gaps in talent, scale-up, an
मानसिक आरोग्यविषयक संकटाशी प्रभावीपणे सामना करण्यासाठ�
India must prioritise the development of novel drugs to address the mental health crisis effectively, leveraging its biotechnology and pharmaceutical
Mpoxचा उद्रेक BioE3 लसींची तातडीची गरज अधोरेखित करतो, उत्पादन �
The mpox outbreak highlights the urgent need for vaccines, with India’s BioE3 policy crucial for boosting production and supporting global health ef
During the COVID-19 pandemic, India contributed to the global response by increasing its vaccine development and health diplomacy efforts, underscoring, among others, its potential as a biotechnology powerhouse. The Government of India continued its effort to make progress in biotechnology research and development in the years after, launching the BioE3 policy in 2024. The BioE3 framework aims to develop a US$300-billion bioeconomy in India by 20
